Marker Therapeutics Inc (MRKR)

[poods]

It's a good one to hold IMO and you're not likely going to need to wait for an approval for substantial SP appreciation. Look at the price of cellular I-O companies (Allogene, Iovance, etc.). Prices rise when approvals seem more likely to the market. MRKR just needs to convince the market that the platform works and the MC should rise into the multibillion range, as with these other companies.
Frankly, I'm not sure what it will take to convince the market this is working. Maybe another CR in pancreatic cancer or a couple of more lymphoma CRs. Hard to say what will trigger the awakening.